US government to pay Moderna $176 million to develop mRNA flu vaccine
Jul 02, 2024
Such a vaccine could be used to treat bird flu in people, as concern grows about H5N1 cases spreading in dairy cows across the country, the US Department of Health and Human Services (HHS) noted.
No decline in cardiovascular events seen with COVID-19 vaccine after acute coronary syndromes
Jun 03, 2024
Findings show no significant reduction in primary end point, MACE for those receiving vaccine after acute coronary syndromes
A second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus a single-dose campaign.
No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Electronic nudge for flu vaccination does not improve clinical outcomes
Mar 19, 2024
No significant difference was seen in hospitalization for pneumonia or influenza or in hospitalization for any cause or mortality.
Many US seniors do not intend to vaccinate against RSV
Mar 13, 2024
The primary reasons for vaccine hesitancy include lack of necessity, concerns about side effects and safety, and lack of information.
COVID-19 vaccination linked to lower risk for postinfection outcomes
Mar 13, 2024
A reduced risk was seen for venous thromboembolism, arterial thrombosis/thromboembolism and heart failure.
Tetanus vaccine may be in short supply after company stops production
Feb 29, 2024
Sanofi plans to ramp up production of its version, but doctors should switch to the Tdap shot in the meantime.
Bivalent COVID-19 shot effective for preventing thromboembolic events
Jan 11, 2024
The findings were seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease.